Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 11.513\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCOC(=O)c1[nH]c2ccc(F)cc2c1NC(=O)CN1CCc2cc(OC)c(OC)cc2C1
b.) CC1CCN(CC(=O)Nc2ccc(Cl)cc2[N+](=O)[O-])CC1
c.) CC(CCn1cccn1)NC(=O)CCc1nnc(C2CCCCC2)o1
d.) CC1CCCCN1C(=O)c1cc(F)c(F)cc1Cl
e.) COCCOC(=O)/C=C1/NC(=O)CS1
Answer: c. CC(CCn1cccn1)NC(=O)CCc1nnc(C2CCCCC2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(CCn1cccn1)NC(=O)CCc1nnc(C2CCCCC2)o1
CC(CCn1cccn1)NC(=O)CCc1nnc(C2CCCCC2)o1
3-(5-cyclohexyl-1,3,4-oxadiazol-2-yl)-N-(4-pyrazol-1-ylbutan-2-yl)propanamide